Silvy Lachance

Title: Silvy Lachance: Innovator in Immune Response Enhancement

Introduction

Silvy Lachance is a notable inventor based in Westmount, Canada. He has made significant contributions to the field of immunology, particularly in enhancing immune responses through innovative methods.

Latest Patents

Lachance holds a patent for the "Expansion of NK and DC cells in vivo mediating immune response." This patent describes a method for expanding dendritic (DC) cells and/or natural killer (NK) cells in vivo within a patient. The process involves producing a graft of stem and progenitor cells that are cultured with UM171 or its analogues, which are then expanded before administration to the patient. The increase in the population of DC and NK cells leads to a heightened immune response, which can reduce transplant-related mortality (TRM), severe graft-versus-host disease (GVHD), relapse, and severe viral infections. He has 1 patent to his name.

Career Highlights

Silvy Lachance is affiliated with the Université de Montréal, where he continues to advance research in immunology. His work focuses on innovative methods to improve patient outcomes through enhanced immune responses.

Collaborations

Lachance collaborates with esteemed colleagues, including Guy Sauvageau and Sandra Cohen, who contribute to his research endeavors.

Conclusion

Silvy Lachance's innovative work in expanding immune cells represents a significant advancement in medical science. His contributions have the potential to improve patient care and outcomes in transplant procedures.